JESSICA TAPP: Open Payments
NPI 1093346769 · NEW SMYRNA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,532 in 47 payments from 23 companies in 2025. Trend: 2023 $1,114 · 2024 $1,350 · 2025 $1,532
Food & beverage: $1,514Education: $17
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $296 |
| Novo Nordisk Inc | 6 | $213 |
| Axsome Therapeutics, Inc. | 2 | $153 |
| Actelion Pharmaceuticals US, Inc. | 1 | $121 |
| Mallinckrodt Hospital Products Inc. | 1 | $120 |
| Amgen Inc. | 6 | $107 |
| JAZZ PHARMACEUTICALS INC. | 4 | $89 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $65 |
| PFIZER INC. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
Products named: VRAYLAR, Ozempic, Auvelity, UPTRAVI, ACTHAR, XYWAV, OTEZLA, EVENITY.
Industry payments across FL — which companies pay providers there.
